Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian R Marsh

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Molecular Cancer Therapeutics|February 6, 2025
Evaluation of VLA-4 (Integrin α4β1) as a Shared Target for Radiopharmaceutical Therapy across Solid TumorsJeyshka M Reyes-González, Harikrishnan Rajkumar, Woonghee Lee, et al.
Science Translational Medicine|July 15, 2021
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockadeRavi B Patel, Reinier Hernandez, Peter Carlson, et al.
Radiation Research|April 7, 2021
Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the BrainPaul A Clark, Raghava N Sriramaneni, Amber M Bates, et al.
Theranostics|May 17, 2021
Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapyJustin C Jagodinsky, Won Jong Jin, Amber M Bates, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Molecular Cancer Therapeutics|February 6, 2025
Evaluation of VLA-4 (Integrin α4β1) as a Shared Target for Radiopharmaceutical Therapy across Solid TumorsJeyshka M Reyes-González, Harikrishnan Rajkumar, Woonghee Lee, et al.
Science Translational Medicine|July 15, 2021
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockadeRavi B Patel, Reinier Hernandez, Peter Carlson, et al.
Radiation Research|April 7, 2021
Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the BrainPaul A Clark, Raghava N Sriramaneni, Amber M Bates, et al.
Theranostics|May 17, 2021
Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapyJustin C Jagodinsky, Won Jong Jin, Amber M Bates, et al.
Pageof 2